Objective To evaluate the clinical outcome after aPL (antiphospholipid antibodies)
disappearance in primary APS patients. Methods From a cohort of 70 patients with primary …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by recurrent
vascular thrombosis (VT) and/or pregnancy morbidity (PM) in the presence of persistent …

Background The performance and standardization of anticardiolipin (aCL) and anti-β 2
glycoprotein I antibodies (aβ 2 GPI) tests for the confirmation of diagnosis of …

Antiphospholipid (APL) syndrome is the most common form of acquired thrombophilia. It can
cause significant morbidity and even mortality. The term “APL antibodies” represents a …

Among “extra-criteria” antiphospholipid (aPL) antibodies, anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …

The classification criteria for antiphospholipid syndrome (APS) generate discussion, with a
growing impression that certain patients not fulfilling these criteria might be inadequately …

Background Thrombotic antiphospholipid syndrome (APS) is a systemic autoimmune
disease; its diagnosis requires meeting both clinical and laboratory criteria. Prevalence rates …

The presence of antiphospholipid antibodies (aPL) is essential to diagnose the
antiphospholipid syndrome (APS). Three assays are available to detect the presence of …

Objective Antiphospholipid syndrome (APS) is characterized by the presence of anti-
phospholipid (aPL) antibodies. However, the relationship between the immunoglobulin (Ig) …

See also Devreese KMJ, Ortel TL, Pengo V, de Laat B, for the Subcommittee on Lupus
Anticoagulant/Antiphospholipid ID Antibodies. Laboratory criteria for antiphospholipid …